Eyepoint pharmaceuticals, inc. (EYPT)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11
Assets
Current assets:
Cash and cash equivalents

26,299

22,214

31,760

44,161

43,379

45,261

55,764

38,776

16,346

12,876

11,833

16,898

12,871

11,685

14,308

15,313

24,867

11,210

14,088

19,121

23,007

29,751

11,384

15,334

18,555

15,219

14,546

6,899

7,998

9,409

8,388

4,625

6,375

8,408

9,811

12,912

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,679

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

2,499

5,847

8,238

-

8,407

9,881

9,917

9,414

8,651

5,935

2,924

2,944

2,712

502

1,908

3,374

5,699

6,311

9,258

9,946

10,087

10,272

11,460

11,216

Accounts and other receivables, net

14,390

11,368

8,855

9,598

2,258

627

489

353

478

288

287

251

300

457

462

488

472

573

569

622

430

727

25,462

517

613

636

1,112

597

1,035

948

938

967

985

1,016

723

843

Prepaid expenses and other current assets

5,647

5,997

3,887

3,144

1,849

1,434

1,389

780

851

481

427

591

800

546

495

483

532

198

589

681

989

935

915

547

582

875

1,546

1,594

473

142

316

421

448

157

286

395

Inventory

3,358

2,138

2,559

1,670

886

279

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current assets

49,694

41,717

47,061

58,573

48,372

47,601

57,642

39,909

17,675

13,645

12,547

17,740

16,470

18,535

23,503

29,963

34,278

21,862

25,163

29,838

33,077

37,348

40,685

19,342

22,462

17,232

19,112

12,464

15,205

16,810

18,900

15,959

17,895

19,853

22,280

25,366

Property and equipment, net

425

357

386

417

425

288

320

253

250

293

337

313

241

231

257

290

311

311

318

338

280

265

261

297

292

133

146

179

223

277

289

335

410

423

397

123

Operating lease right-of-use assets

2,967

3,078

3,186

3,291

3,393

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

27,054

27,669

28,284

28,899

29,514

30,129

30,743

31,358

31,973

0

184

364

540

718

910

1,102

1,311

1,512

1,713

1,925

2,080

2,301

2,528

2,765

2,940

3,127

3,300

3,430

3,619

3,883

4,078

4,226

4,451

4,596

20,387

21,564

Other assets

-

-

-

-

-

-

-

0

110

109

109

110

104

112

113

114

115

115

116

116

115

116

116

117

177

177

177

176

73

72

72

77

77

76

76

60

Restricted cash

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

150

-

-

-

-

-

-

-

-

-

-

Total assets

80,290

72,971

79,067

91,330

81,854

78,168

88,855

71,670

50,158

14,197

13,327

18,677

17,505

19,746

24,933

31,619

36,165

23,950

27,460

32,367

35,702

40,180

43,740

22,671

26,021

20,819

22,735

16,249

19,120

21,042

23,339

20,597

22,833

24,948

43,140

47,113

Liabilities and stockholders' equity
Current liabilities:
Accounts payable

5,158

4,192

5,461

6,066

6,318

2,640

4,075

2,940

2,760

1,483

1,756

1,016

741

1,110

1,015

1,363

571

303

893

744

812

384

1,105

464

761

176

1,082

671

355

215

266

394

346

262

511

328

Accrued expenses

4,559

6,832

4,446

4,214

2,924

3,789

3,343

3,723

3,215

2,262

2,513

4,224

3,943

3,681

3,688

3,583

3,378

3,552

2,067

2,571

1,371

1,820

1,103

1,524

1,203

1,204

1,087

1,894

1,437

1,084

801

608

778

650

845

1,322

Accrued development milestone

-

-

-

-

15,000

15,000

15,000

15,000

15,000

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

30

15

-

-

0

30

-

0

240

505

10

50

256

136

139

147

19

28

33

33

35

69

104

138

312

771

688

738

893

784

2,395

2,176

1,465

1,722

2,509

3,212

Other current liabilities

551

481

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities - current portion

-

-

461

441

417

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

128

170

Total current liabilities

10,298

11,520

10,368

10,721

24,659

21,459

22,418

21,663

21,215

4,250

4,279

5,290

4,940

4,927

4,842

5,093

3,968

3,883

2,993

3,348

2,218

2,273

2,312

2,126

2,276

2,151

2,857

3,303

2,685

2,083

3,462

3,178

2,589

2,634

3,993

5,032

Long-term debt

47,716

47,223

46,733

46,250

31,952

17,621

17,463

17,309

12,850

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities - noncurrent

2,764

2,898

3,028

3,149

3,266

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

-

-

-

-

-

-

0

19,780

6,957

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

3,038

3,000

3,000

3,000

2,100

1,455

1,269

1,231

938

-

-

51

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, less current portion

-

-

-

-

-

-

-

-

-

-

-

-

0

0

5,585

5,585

5,584

5,584

5,587

5,596

5,584

5,584

5,584

5,584

5,388

6,069

5,641

5,246

5,194

5,149

3,714

3,783

4,689

4,521

3,915

4,635

Deferred rent

-

-

-

-

-

-

-

-

-

42

47

-

55

57

58

60

60

59

57

55

53

48

42

37

11

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13

Total liabilities

63,816

64,641

63,129

63,120

61,977

40,535

41,150

59,983

41,960

4,292

4,326

5,341

4,995

4,984

10,485

10,738

9,612

9,526

8,637

8,999

7,855

7,905

7,938

7,747

7,675

8,220

8,498

8,549

7,879

7,232

7,176

6,961

7,278

7,155

7,908

9,680

Contingencies (Note 12)

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

-

0

-

0

-

-

-

0

Stockholders' equity:
Preferred stock, $.001 par value, 5,000,000 shares authorized, no shares issued and outstanding

0

0

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $.001 par value, 150,000,000 shares authorized at March 31, 2020 and December 31, 2019; 124,741,832 and 109,417,322 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

125

109

108

106

96

95

95

74

54

45

40

39

35

34

34

34

34

29

29

29

29

29

29

29

29

27

27

23

23

23

23

21

21

21

21

21

Additional paid-in capital

493,969

472,667

469,866

466,493

446,673

445,192

443,671

374,766

336,870

331,609

324,927

323,284

316,233

313,347

312,951

312,208

311,463

294,286

293,474

293,060

-

-

-

290,864

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

292,439

291,825

291,229

-

290,344

282,416

280,570

270,415

270,015

269,703

269,440

264,431

264,041

263,662

263,497

262,906

Accumulated deficit

-478,460

-465,286

-454,876

-439,229

-427,731

-408,493

-396,899

-363,991

-329,563

-322,585

-316,803

-310,820

-304,582

-299,442

-299,375

-292,213

-285,826

-280,785

-275,599

-270,666

-265,520

-260,522

-256,447

-277,013

-273,046

-270,859

-267,345

-263,658

-259,711

-256,917

-254,309

-251,758

-249,496

-246,810

-229,350

-226,923

Accumulated other comprehensive income

840

840

840

840

839

839

838

838

837

836

837

833

824

823

838

852

882

894

919

945

899

943

991

1,044

1,019

1,015

985

920

914

1,001

1,009

942

989

920

1,064

1,429

Total stockholders' equity

16,474

8,330

15,938

28,210

19,877

37,633

47,705

11,687

8,198

9,905

9,001

13,336

12,510

14,762

14,448

20,881

26,553

14,424

18,823

23,368

27,847

32,275

35,802

14,924

18,346

12,599

14,237

7,700

11,241

13,810

16,163

13,636

15,555

17,793

35,232

37,433

Total liabilities and stockholders' equity

80,290

72,971

79,067

91,330

81,854

78,168

88,855

71,670

50,158

14,197

13,327

18,677

17,505

19,746

24,933

31,619

36,165

23,950

27,460

32,367

35,702

40,180

43,740

22,671

26,021

20,819

22,735

16,249

19,120

21,042

23,339

20,597

22,833

24,948

43,140

47,113